Literature DB >> 15309085

Neuropeptide Y and Epilepsy.

William F. Colmers1, Bouchaïb El Bahh.   

Abstract

It is a central tenet of the epilepsy field that seizures result from the imbalance of excitation over inhibition (1). The bulk of excitation is mediated by the neurotransmitter glutamate, whereas inhibition results mainly from the actions of gamma-aminobutyric acid (GABA). In the neocortex and hippocampus, the intrinsic sources of GABA are the interneurons, which lately have come under intense scrutiny. It has become clear that a large number of distinct types of interneurons can be differentiated in part by the array of neuropeptides they coexpress (cf. (2)). Evidence is emerging that the neuropeptide complement of interneurons plays important roles in the way that interneurons regulate excitability. Here we discuss what is known about the relation of one well-characterized neuropeptide, neuropeptide Y (NPY), and epilepsy in experimental animals and humans, and suggest possible roles for the receptors as targets for the control of excessive excitation in epilepsy.

Entities:  

Year:  2003        PMID: 15309085      PMCID: PMC321170          DOI: 10.1111/j.1535-7597.2003.03208.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.872


  50 in total

1.  Mechanism of presynaptic inhibition by neuropeptide Y at sympathetic nerve terminals.

Authors:  P T Toth; V P Bindokas; D Bleakman; W F Colmers; R J Miller
Journal:  Nature       Date:  1993-08-12       Impact factor: 49.962

2.  Role of the Y5 neuropeptide Y receptor in limbic seizures.

Authors:  D J Marsh; S C Baraban; G Hollopeter; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

3.  Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes.

Authors:  M Bijak
Journal:  Neurosci Lett       Date:  1999-06-25       Impact factor: 3.046

4.  Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry.

Authors:  J Qian; W F Colmers; P Saggau
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

5.  Somatostatin- and neuropeptide Y-synthesizing neurones in the fascia dentata of humans with temporal lobe epilepsy.

Authors:  L E Sundstrom; C Brana; M Gatherer; J Mepham; A Rougier
Journal:  Brain       Date:  2001-04       Impact factor: 13.501

6.  Neuropeptide Y inhibits hippocampal seizures and wet dog shakes.

Authors:  D P Woldbye; T M Madsen; P J Larsen; J D Mikkelsen; T G Bolwig
Journal:  Brain Res       Date:  1996-10-21       Impact factor: 3.252

7.  On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro.

Authors:  G J Klapstein; W F Colmers
Journal:  Hippocampus       Date:  1993-01       Impact factor: 3.899

8.  Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain.

Authors:  C Köhler; L Eriksson; S Davies; V Chan-Palay
Journal:  J Comp Neurol       Date:  1986-02-15       Impact factor: 3.215

9.  Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains.

Authors:  Y Dumont; D Jacques; P Bouchard; R Quirion
Journal:  J Comp Neurol       Date:  1998-12-21       Impact factor: 3.215

10.  Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors.

Authors:  M Gariboldi; M Conti; D Cavaleri; R Samanin; A Vezzani
Journal:  Eur J Neurosci       Date:  1998-02       Impact factor: 3.386

View more
  29 in total

Review 1.  Neuropeptide Y in the recurrent mossy fiber pathway.

Authors:  J Victor Nadler; Bin Tu; Olga Timofeeva; Yiqun Jiao; Herbert Herzog
Journal:  Peptides       Date:  2007-01-03       Impact factor: 3.750

2.  Valproate enhances neuropeptide y expression: modulating the modulators.

Authors:  Andre H Lagrange
Journal:  Epilepsy Curr       Date:  2007 Jul-Aug       Impact factor: 7.500

3.  Overexpression of neuropeptide Y decreases responsiveness to neuropeptide Y.

Authors:  Katelynn M Corder; Qin Li; Mariana A Cortes; Aundrea F Bartley; Taylor R Davis; Lynn E Dobrunz
Journal:  Neuropeptides       Date:  2019-11-07       Impact factor: 3.286

Review 4.  Physiological and Therapeutic Roles of Neuropeptide Y on Biological Functions.

Authors:  Pravin Shende; Drashti Desai
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Establishment of a mouse model for injury-induced scar formation and the accompanying chronic pain: Comprehensive microarray analysis of molecular expressions in fibrosis and hyperalgesia.

Authors:  Yuqiang Li; Hiroki Iida; Koji Kimata; Lisheng Zhuo; Akinobu Ota; Shinya Kimura; Xiaojian Yin; Masataka Deie; Takahiro Ushida
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

6.  Neuropeptide Y levels are associated with nutritional status and cardiovascular events in adults with chronic kidney disease.

Authors:  L Lu; Y-C Zou; M Wang; Y-F Huang; D-X Chen; L-B Wei
Journal:  Eur J Clin Nutr       Date:  2015-04-29       Impact factor: 4.016

7.  Cyclohexane Inhalation Produces Long-Lasting Alterations in the Hippocampal Integrity and Reward-Seeking Behavior in the Adult Mouse.

Authors:  Tania Campos-Ordonez; David Zarate-Lopez; Nereida Ibarra-Castaneda; Jonathan Buritica; Oscar Gonzalez-Perez
Journal:  Cell Mol Neurobiol       Date:  2019-02-15       Impact factor: 5.046

8.  Targeted deletion of betaIII spectrin impairs synaptogenesis and generates ataxic and seizure phenotypes.

Authors:  Michael C Stankewich; Babette Gwynn; Thomas Ardito; Lan Ji; Jung Kim; Raymond F Robledo; Samuel E Lux; Luanne L Peters; Jon S Morrow
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

9.  NPY Receptors Blockade Prevents Anticonvulsant Action of Ghrelin in the Hippocampus of Rat.

Authors:  Mina Ghahramanian Golzar; Shirin Babri; Zohre Ataie; Hadi Ebrahimi; Fariba Mirzaie; Gisou Mohaddes
Journal:  Adv Pharm Bull       Date:  2013-08-20

10.  Abnormalities in cortical interneuron subtypes in ephrin-B mutant mice.

Authors:  Asghar Talebian; Rachel Britton; Mark Henkemeyer
Journal:  Eur J Neurosci       Date:  2018-07-10       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.